Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Alibaba Health Information Technology ( (HK:0241) ) has provided an announcement.
Alibaba Health Information Technology Limited has scheduled a board meeting for May 14, 2026, to review and approve the audited financial results for the year ended March 31, 2026. The board will also consider whether to recommend a final dividend, a decision that could signal the company’s profitability and capital-allocation stance to shareholders.
The outcome of this meeting will shape how Alibaba Health returns value to investors and may influence market expectations for its growth trajectory in the health-technology space. Investors will be watching the final results and any dividend proposal as indicators of operational performance, financial health and the board’s confidence in future prospects.
The most recent analyst rating on (HK:0241) stock is a Sell with a HK$4.60 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited is a Bermuda-incorporated company listed in Hong Kong that operates in the healthcare and health-technology sector. It focuses on providing digital health services and related healthcare solutions to consumers and partners in the Chinese market and beyond.
Average Trading Volume: 86,696,036
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$72.28B
Find detailed analytics on 0241 stock on TipRanks’ Stock Analysis page.